• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-19A
Device Problem Torn Material (3024)
Patient Problems Aortic Regurgitation (1716); Death (1802)
Event Date 04/24/2018
Event Type  Death  
Event Description
On (b)(6) 2013, an aortic valve replacement (avr) was performed with a 19 mm trifecta valve.In (b)(6) 2018, the patient presented cardiac failure due to severe aortic regurgitation (ar).An echocardiogram was performed and perivalvular leakage (pvl) was diagnosed.The physician believed the best procedure for treatment was to use vascular plugs to stop the pvl.On (b)(6) 2018, the physician attempted to close the pvl with vascular plug devices, but the leakage could not be controlled.Eventually, the procedure was aborted with the trifecta valve still in the patient.It is reported the patient later expired.The physician believes "as the patient's general condition had deteriorated prior to the procedure, it most likely related to her death." an autopsy was performed and pathological analysis on the valve performed.When the valve was explanted from the patient, the right coronary cusp and left coronary cusp was noted to have been torn.According to the physician, the tear sites were likely enlarged during the deployment procedure of the vascular plugs.Information on the manufacturer of the vascular plugs were not provided.
 
Manufacturer Narrative
An event of perivalvular leakage was reported.The reported leaflet tears were confirmed.All 3 leaflets contained tears.Fibrous pannus ingrowth was observed focally on the inflow surface of leaflet 1.No inflammations or significant calcifications were found to be present.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.The reported event remains unknown.
 
Event Description
On (b)(6) 2013, an aortic valve replacement (avr) was performed with a 19 mm trifecta valve.In (b)(6) 2018, the patient presented in cardiac failure due to severe aortic regurgitation (ar).An echocardiogram was performed and perivalvular leakage (pvl) was diagnosed.The physician believed the best procedure for treatment was to use vascular plugs off-label to stop the pvl.On (b)(6) 2018, the physician attempted to close the pvl with five vascular plug devices (2 of model 9-avp2-006; 2 of model 9-avp2-008 and 1 of model 9-avp2-012) however; the pvl was unable to be controlled (stopped) and the procedure was aborted.There was no impact to the pvl or the implanted tricuspid valve.Information was not provided on whether the vascular plugs were left within the patient or removed.It was reported that a later point in time, the patient expired.The physician reported that "as the patient's general condition had deteriorated prior to the procedure, it most likely related to her death." an autopsy was performed and pathological analysis on the valve performed.When the valve was explanted from the patient, the right coronary cusp and left coronary cusp was noted to have been torn.Evidence of pvl was not confirmed and it was not possible to confirm the time of the valve tears.According to the physician, the tear sites were likely enlarged during the deployment procedure of the vascular plugs.No additional information including the serial number and implant date of this valve was made available despite abbott request.Patient specific information on patient identifier and weight are not available for this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
Manufacturer (Section G)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR   31310-260
Manufacturer Contact
elizabeth boltz
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key7540381
MDR Text Key109125347
Report Number3001883144-2018-00044
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 08/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/03/2015
Device Model NumberTF-19A
Device Catalogue NumberTF-19A
Device Lot Number4155643
Other Device ID Number05414734052016
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/12/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/25/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/04/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
Patient Age82 YR
-
-